Please provide your email address to receive an email when new articles are posted on . Veligrotug improved proptosis, diplopia and clinical activity score in patients with active or chronic thyroid ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Veligrotug for chronic thyroid eye disease yielded ...
In a phase III trial, the investigational subcutaneous monoclonal antibody elegrobart demonstrated greater reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results